Skip to main content

Table 4 Bivariate and multivariate logistic regression models (associations between MHA status and psychotropic prescribing on discharge)

From: Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study

Model 1an = 800

 

MHA Status

Crude Odds Ratio

Adjusted Odds Ratio

Variable

Voluntary

Involuntary

(95% CI)

(95% CI)

 Antipsychotic

n (%)

n (%)

  

  None

144 (28.4)

9 (3.1)

Reference

Reference

  One

291 (57.4)

137 (46.7)

7.53 (3.73,15.22)**

2.71 (1.22, 6.04)*

   > One

72 (14.2)

147 (50.2)

32.7 (15.7, 67.8)**

8.80 (3.69, 20.98)**

 Antidepressant

n (%)

n (%)

  

  None

237 (46.8)

236 (80.5)

Reference

Reference

  One

243 (47.9)

53 (18.1)

0.22 (0.15, 0.31)**

0.47 (0.30, 0.74)*

   > One

27 (5.3)

4 (1.4)

0.15 (0.05, 0.43)**

0.31 (0.08, 1.19)

 Mood stabiliser

n (%)

n (%)

  

  None

407 (80.3)

192 (65.5)

Reference

Reference

  One

90 (17.7)

84 (28.7)

1.98 (1.40, 2.79)**

1.35 (0.84, 2.17)

   > One

10 (2.0)

17 (5.8)

3.60 (1.62, 8.02)*

2.17 (0.80, 5.89)

 Benzodiazepine

n (%)

n (%)

  

  None

354 (69.8)

225 (76.8)

Reference

Reference

  One/Two

153 (30.2)

68 (23.2)

0.70 (0.50, 0.97)*

1.00 (0.66, 1.53)

Models 2, 3 and 4b

 

MHA Status

Crude Odds Ratio

Adjusted Odds Ratio

Variable

Voluntary

Involuntary

(95% CI)

(95% CI)

Model 2 n = 647

n (%)

n (%)

  

Cumulative antipsychotic equivalent total dose > 1

56 (15.4)

102 (35.9)

3.07 (2.11, 4.47)**

1.65 (1.05, 2.59)*

Model 3 n = 327

n (%)

n (%)

  

Cumulative antidepressant equivalent total dose > 1

36 (13.3)

9 (15.8)

1.22 (0.55, 2.70)

1.05 (0.37, 2.97)

Model 4 n = 221

n (%)

n (%)

  

Cumulative benzodiazepine equivalent total dose > 1

4 (2.6)

2 (2.9)

1.13 (0.20, 6.32)

0.92 (0.12,6.74)

  1. *p < 0.05, **p < 0.001
  2. CI confidence interval, ECT Electroconvulsive therapy
  3. aAdjusted for age, gender, country of birth, year of admission length of admission, admissions in last 12 months, primary diagnosis, ECT during admission, previous clozapine treatment, and three other psychotropic medicines groups on discharge;
  4. bAdjusted for age, gender, country of birth, year of admission, length of admission, admissions in last 12 months, primary diagnosis, ECT during admission, previous clozapine treatment, and total number of psychotropic medicines on discharge;